Increasing evidence suggests that low-grade immune activation in the gut can influence brain signaling, leading to symptoms such as fatigue, brain fog and mood changes which are often present in disorders of brain gut interactions. The biggest mediator behind these outcomes? The brain gut microbiome system: a bidirectional communication system highly susceptible to immune dysregulation, with mast cells, cytokines and the vagus nerve being key players in this process.
Low-Grade Immune Activation in the Gut
Irritable Bowel Syndrome (IBS) is a complex gastrointestinal disorder with symptoms that extend far beyond the typical digestive system, chronic abdominal pain and altered bowel habits. Individuals with IBS often exhibit subtle yet chronic immune activation in the gut, characterized by increased levels of immune cells and other inflammatory mediators. Unlike acute inflammation, which is seen in inflammatory bowel disorders like ulcerative colitis and Chron’s disease, the immune activation seen in some IBS patients is typically low-grade but persistent. This prolonged immune response can result in increased intestinal permeability, commonly referred to as “leaky gut,” which essentially allows immune cells and inflammatory cytokines to influence distant organs. Sometimes, they may even reach and affect the brain. Still, one big question remains: What actually kicks off this immune system disruption in the first place? While inflammation certainly serves as a mediator, the causes that precede inflammation aren’t fully understood. Stress, for example, can mess with the hypothalamic-pituitary-adrenal (HPA) axis (a key stress-response system), and if leaky gut is present, then food intolerances may also stir up the immune system. Therefore, clinically, the challenge lies in pinpointing which patients share the same underlying mechanisms. Without clear signs highlighting the root cause, tailoring effective treatments can become challenging.
Mast Cells and Cytokines: Key Immune Players
Mast cells are abundant in the gut lining and have been implicated in IBS-related immune activation. These cells release histamine, tryptase, and various cytokines in response to triggers such as stress, diet, or microbiome imbalances. Elevated levels of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), contribute to visceral hypersensitivity, pain, and motility disturbances commonly experienced in IBS patients. Cytokines act as signaling molecules that not only modulate inflammation in the gut but also have systemic effects on the brain. For example, elevated inflammatory cytokines can disrupt neurotransmitter balance and contribute to neuroinflammation, which is implicated in cognitive dysfunction and mood disorders.
The Vagus Nerve: A Critical Communication Pathway
The afferent branches of the vagus nerve serve as the major communication pathways between the gut and the brain, transmitting signals that influence brain activity, mood regulation, and immune responses. Chronic low-grade inflammation in the gut can alter vagal signaling and reduce its ability to exert anti-inflammatory effects. Additionally, impaired vagus nerve function can lead to dysregulation of the HPA axis, which can exacerbate the stress responses and feed into the cycle of inflammation, gut dysmotility, and even heightened pain perception.
These are just a few ways in which gut-derived immune activation may contribute to symptoms often reported in IBS, such as fatigue, brain fog, and mood disturbances. Many of the cognitive effects can be traced back to neuroinflammation impairing mitochondrial function and neurotransmitter production, leading to reduced mental clarity. Alternatively, the prominent role of serotonin and dopamine levels in the gut brain communication may explain why IBS patients frequently experience symptoms of anxiety and depression alongside their gastrointestinal discomfort.
Conclusion
The interplay between low-grade immune activation in the gut and brain signaling explains why IBS is more than just a gastrointestinal disorder. Mast cells, cytokines, and the vagus nerve act as crucial modulators in this gut-brain communication, influencing both digestive, emotional and neurological symptoms. Understanding these mechanisms opens the door for targeted therapies aimed at reducing neuroinflammation and restoring gut-brain balance, ultimately improving the quality of life for those suffering from disorders of brain gut interactions.

Monica Echeverri holds a Master of Science in Human Nutrition and Functional Medicine from the University of Western States and currently works as a food photographer, writer, and recipe developer.
✓ This article was reviewed and approved by Emeran Mayer, MD